Valuation: Seer, Inc.

Market Cap 119M 104M 95.94M 88.64M 167M 11.41B 170M 1.14B 449M 5.59B 446M 436M 19.23B P/E 2026 *
-2.07x
P/E 2027 * -2.2x
Enterprise Value 119M 104M 95.94M 88.64M 167M 11.41B 170M 1.14B 449M 5.59B 446M 436M 19.23B EV / Sales 2026 *
7.31x
EV / Sales 2027 * 5.67x
Free-Float
85.54%
Yield 2026 *
-
Yield 2027 * -
1 day+0.46%
1 week-0.69%
Current month+30.42%
1 month+26.61%
3 months+10.46%
6 months+13.35%
Current year+18.31%
1 week 2.14
Extreme 2.14
2.23
1 month 1.55
Extreme 1.55
2.34
Current year 1.55
Extreme 1.55
2.34
1 year 1.55
Extreme 1.55
2.41
3 years 1.46
Extreme 1.455
5.65
5 years 1.46
Extreme 1.455
45.85
10 years 1.46
Extreme 1.455
86.55
Manager TitleAgeSince
Chief Executive Officer 57 2018-02-28
Director of Finance/CFO 58 2020-04-30
Chief Operating Officer - -
Director TitleAgeSince
Chairman 57 2020-08-31
Director/Board Member 76 2017-11-30
Director/Board Member 70 2017-11-30
Date Insider Type Main position Quantity % Market Cap.
07-07Sell

Director

-10,660 0.0193%
05-19Sell

Chief Financial Officer

-7,303 0.0129%
05-07Free

Executive/Senior Manager

300,000 0.5317%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%-0.69%+3.10%-56.09% 119M
+0.77%+6.24%+13.55%-0.12% 26.57B
+1.07%+6.95%+25.73%-2.38% 7.52B
-1.59%+10.34%+111.31%+200.83% 4.57B
-0.59%+9.95%+15.24%-45.83% 2.87B
+6.62%+17.75%+92.85%+71.94% 2.37B
-0.41%-4.34%+170.64%+131.00% 2.22B
-0.65%-9.99%+25.43%+18.30% 1.81B
-2.17%-8.30%-18.39%+30.72% 1.16B
-7.41%-1.47%+95.21%+66.05% 1.02B
Average -0.40%+2.50%+53.47%+41.44% 5.02B
Weighted average by Cap. +0.43%+2.76%+36.38%+27.00%

Financials

2026 *2027 *
Net sales 16.25M 14.2M 13.13M 12.13M 22.84M 1.56B 23.25M 157M 61.42M 764M 61.04M 59.69M 2.63B 20.95M 18.31M 16.92M 15.64M 29.45M 2.01B 29.98M 202M 79.19M 985M 78.69M 76.95M 3.39B
Net income -58.65M -51.25M -47.38M -43.77M -82.43M -5.63B -83.93M -565M -222M -2.76B -220M -215M -9.5B -55.7M -48.68M -45M -41.57M -78.29M -5.35B -79.71M -537M -211M -2.62B -209M -205M -9.02B
Net Debt - -
Logo Seer, Inc.
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Employees
124
Date Price Change Volume
26-07-15 US$2.165 +0.23% 72,591
26-07-14 US$2.160 -0.46% 142,655
26-07-13 US$2.170 0.00% 365,132
26-07-10 US$2.170 -1.36% 301,330
26-07-09 US$2.200 +0.92% 419,416
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.160USD
Average target price
4.000USD
Spread / Average Target
+85.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEER Stock